Vulvovaginal Atrophy: Clinical Trials

8 trials for Vulvovaginal Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 6, Unknown 2

Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain
Prasterone 6.5 MG, Placebo - Vulvovaginal Atrophy
Phase 3UnknownDr. Santiago Palacios502020-12-222021-06-02
Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
Estradiol 10 MCG Vaginal Tablet [VAGIFEM], Promestriene Vaginal - Vulvovaginal Atrophy
Phase 3CompletedInstituto Palacios1202020-01-092021-02-11
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause
Phase 3UnknownCenter for Vulvovaginal Disorders402019-03-022019-01-31
Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy
CO2 laser, Estrogen, Placebo of Estrogen - Vulvovaginal Atrophy
Phase 3CompletedFaculdade de Medicina do ABC452015-03-012016-06-28
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
Estradiol, Placebo - Vulvovaginal Atrophy, Menopause
Phase 3CompletedTherapeuticsMD7642014-09-012017-05-25
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
WC3011 Estradiol Vaginal Cream, Vehicle - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott5502013-04-122022-05-09
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
Vehicle, WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott5762013-01-312022-05-09
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott3092011-10-202022-05-09

Narrower conditions

Dyspareunia (5)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Female (5)  ·  Genital Diseases, Male (5)  ·  Male Urogenital Diseases (5)  ·  Mental Disorders (5)  ·  Sexual Dysfunction, Physiological (5)  ·  Sexual Dysfunctions, Psychological (5)  ·  Urogenital Diseases (5)

Interventions

Dehydroepiandrosterone (2)  ·  Estradiol (2)  ·  Control Groups (1)  ·  Estriol (1)  ·  Estrogens (1)  ·  Lasers, Gas (1)  ·  Vaginal Creams, Foams, and Jellies (1)

Sponsors

Warner Chilcott (3)  ·  Center for Vulvovaginal Disorders (1)  ·  Dr. Santiago Palacios (1)  ·  Faculdade de Medicina do ABC (1)  ·  Instituto Palacios (1)  ·  TherapeuticsMD (1)

Countries

United States (5)  ·  Spain (2)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Anna Chan, PharmD (3)  ·  Fernand Labrie, MD (1)  ·  Vera L da Cruz, MD (1)

Results publications

PMID 15779109, PMID 24605832, PMID 25333211, PMID 28355090, PMID 30238814, PMID 31688572, PMID 34054104, PMID 34813408, PMID 37619252, PMID 40709601